Exosens Stock Breaks Key Resistance at 65.30 Euros, Up 43% in Three Months
Exosens continues its upward trend this Thursday, March 5, with a share price reaching 66.60 euros, up 2.78% from the previous day. The photon detection and amplification technology specialist's stock now shows a gain of nearly 12% over seven days and more than 43% over three months. This acceleration occurs amid geopolitical tensions in the Middle East and following a target price upgrade by an analyst earlier in the week.
Analyst Upgrade Boosts Exosens Outlook
On Monday, March 3, the research firm Bernstein raised its price target on Exosens from 61.00 euros to 72.50 euros, while maintaining its 'outperform' rating. At the current price of 66.60 euros, this new target represents a potential upside of approximately 8.9%. This upgrade comes as the company, listed on Euronext Paris since 2024, operates in the high-performance optoelectronics and sensors sector, with applications spanning defense, aerospace, and nuclear industries. The next financial milestone on the calendar is the publication of the first quarter 2026 results, expected on April 27, followed by the annual general meeting scheduled for May 22.
Technical Breakthrough in Today's Session
From a technical perspective, today's session marks a significant event: the share price of 66.60 euros has surpassed the identified resistance at 65.30 euros as well as the upper Bollinger band at 66.51 euros. This simultaneous breach signals an acceleration of the short-term bullish trend, although the distance of the stock from this band may also indicate a marked extension from its recent dynamics. Concurrently, the Relative Strength Index (RSI) stands at 72, a level indicating an overbought zone, meaning that buying pressure has been particularly strong in recent sessions. The stock is trading well above its 50-day moving average, set at 55.33 euros, and even more so above its 200-day average (45.95 euros), confirming the strength of the upward trend initiated in recent months. The annual performance now exceeds 111%, illustrating the continuous revaluation trajectory of the stock since its IPO.
